Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Donatella Boschi

Showing results (21-30 of 51) with videos related to

Pageof 6
Sort By:
Antiviral Research|March 15, 2021
Effective deploying of a novel DHODH inhibitor against herpes simplex type 1 and type 2 replicationAnna Luganini, Giulia Sibille, Barbara Mognetti, et al.
Antiviral Research|October 18, 2023
Mechanisms of antiviral activity of the new hDHODH inhibitor MEDS433 against respiratory syncytial virus replicationAnna Luganini, Giulia Sibille, Marta Pavan, et al.
European Journal of Medicinal Chemistry|September 18, 2018
4-Hydroxy-1,2,3-triazole moiety as bioisostere of the carboxylic acid function: a novel scaffold to probe the orthosteric γ-aminobutyric acid receptor binding siteAlessandro Giraudo, Jacob Krall, Birgitte Nielsen, et al.
Journal of Medicinal Chemistry|May 12, 2006
NO-donor phenols: a new class of products endowed with antioxidant and vasodilator propertiesDonatella Boschi, Gian Cesare Tron, Loretta Lazzarato, et al.
Bioorganic & Medicinal Chemistry|July 16, 2014
Furazan and furoxan sulfonamides are strong α-carbonic anhydrase inhibitors and potential antiglaucoma agentsKonstantin Chegaev, Loretta Lazzarato, Yasinalli Tamboli, et al.
Acta Crystallographica. Section D, Structural Biology|May 28, 2024
An alternative conformation of the N-terminal loop of human dihydroorotate dehydrogenase drives binding to a potent antiproliferative agentMarta Alberti, Giulio Poli, Luca Broggini, et al.
Brain Sciences|January 21, 2022
A New NF-κB Inhibitor, MEDS-23, Reduces the Severity of Adverse Post-Ischemic Stroke Outcomes in RatsElina Rubin, Agnese C Pippione, Matthew Boyko, et al.
Medchemcomm|November 2, 2019
Exploration of [2 + 2 + 2] cyclotrimerisation methodology to prepare tetrahydroisoquinoline-based compounds with potential aldo-keto reductase 1C3 target affinityAna R N Santos, Helen M Sheldrake, Ali I M Ibrahim, et al.
Medchemcomm|August 16, 2018
4-Hydroxy-<i>N</i>-[3,5-bis(trifluoromethyl)phenyl]-1,2,5-thiadiazole-3-carboxamide: a novel inhibitor of the canonical NF-κB cascadeAgnese C Pippione, Antonella Federico, Alex Ducime, et al.
Medchemcomm|August 16, 2018
<i>N</i>-Acetyl-3-aminopyrazoles block the non-canonical NF-kB cascade by selectively inhibiting NIKAgnese C Pippione, Stefano Sainas, Antonella Federico, et al.
Pageof 6

Showing results (21-30 of 51) with videos related to

Sort By:
Pageof 6
Antiviral Research|March 15, 2021
Effective deploying of a novel DHODH inhibitor against herpes simplex type 1 and type 2 replicationAnna Luganini, Giulia Sibille, Barbara Mognetti, et al.
Antiviral Research|October 18, 2023
Mechanisms of antiviral activity of the new hDHODH inhibitor MEDS433 against respiratory syncytial virus replicationAnna Luganini, Giulia Sibille, Marta Pavan, et al.
European Journal of Medicinal Chemistry|September 18, 2018
4-Hydroxy-1,2,3-triazole moiety as bioisostere of the carboxylic acid function: a novel scaffold to probe the orthosteric γ-aminobutyric acid receptor binding siteAlessandro Giraudo, Jacob Krall, Birgitte Nielsen, et al.
Journal of Medicinal Chemistry|May 12, 2006
NO-donor phenols: a new class of products endowed with antioxidant and vasodilator propertiesDonatella Boschi, Gian Cesare Tron, Loretta Lazzarato, et al.
Bioorganic & Medicinal Chemistry|July 16, 2014
Furazan and furoxan sulfonamides are strong α-carbonic anhydrase inhibitors and potential antiglaucoma agentsKonstantin Chegaev, Loretta Lazzarato, Yasinalli Tamboli, et al.
Acta Crystallographica. Section D, Structural Biology|May 28, 2024
An alternative conformation of the N-terminal loop of human dihydroorotate dehydrogenase drives binding to a potent antiproliferative agentMarta Alberti, Giulio Poli, Luca Broggini, et al.
Brain Sciences|January 21, 2022
A New NF-κB Inhibitor, MEDS-23, Reduces the Severity of Adverse Post-Ischemic Stroke Outcomes in RatsElina Rubin, Agnese C Pippione, Matthew Boyko, et al.
Medchemcomm|November 2, 2019
Exploration of [2 + 2 + 2] cyclotrimerisation methodology to prepare tetrahydroisoquinoline-based compounds with potential aldo-keto reductase 1C3 target affinityAna R N Santos, Helen M Sheldrake, Ali I M Ibrahim, et al.
Medchemcomm|August 16, 2018
4-Hydroxy-<i>N</i>-[3,5-bis(trifluoromethyl)phenyl]-1,2,5-thiadiazole-3-carboxamide: a novel inhibitor of the canonical NF-κB cascadeAgnese C Pippione, Antonella Federico, Alex Ducime, et al.
Medchemcomm|August 16, 2018
<i>N</i>-Acetyl-3-aminopyrazoles block the non-canonical NF-kB cascade by selectively inhibiting NIKAgnese C Pippione, Stefano Sainas, Antonella Federico, et al.
Pageof 6